General information on prostate cancer assessment and treatment options, and how a review with a urology and oncology team at a partner clinic is coordinated.
Important
This is general information, not medical advice. Cancer care decisions must be made with your treating oncologist. In an emergency, contact your local emergency services.
ELAVIA Global coordinates care; it does not provide medical treatment. All cancer care is delivered by independent partner clinics and their licensed oncologists.
A second opinion is an additional view, not a replacement for your current care. Please do not stop, delay or change any treatment without speaking to your treating team.
Prostate cancer is assessed with a combination of PSA blood tests, examination, MRI and biopsy. The pathology result (the Gleason score or Grade Group), the PSA level and scans showing whether the cancer has spread together define a risk group, which guides the discussion of options.
Depending on the situation, options may include active surveillance (careful monitoring with regular tests), surgery to remove the prostate (radical prostatectomy, often robot-assisted), radiotherapy, hormone therapy, or other systemic treatment for more advanced disease. Some prostate cancers grow very slowly and may not need immediate treatment.
The right approach depends on the features of the cancer, your age, general health and personal priorities, including possible effects on urinary and sexual function. These decisions are made with a urologist and an oncologist after a full review.
You contact a coordinator and describe what you would like reviewed. We explain what we can and cannot do: ELAVIA Global coordinates care and does not give medical advice or treatment.
With your consent, your reports, imaging and pathology are shared securely with an oncologist at an independent partner clinic. Original scan files or pathology slides may need to be re-reviewed, or some tests repeated.
A urologist and an oncologist at the partner clinic review the results and explain the options they consider relevant, with the possible benefits and side effects of each. Further imaging, such as a PSMA PET-CT, may be suggested in some cases.
If you decide to proceed at a partner clinic, surgery or radiotherapy is delivered by its licensed team. Monitoring after treatment usually continues with your doctor at home.
You receive written reports to take home. Ongoing follow-up is usually arranged with your oncologist at home, and the coordinator helps share records between the teams.
These are general examples only. Whether any test or treatment is appropriate is decided by a treating oncologist after examination, imaging and pathology review.
Send copies and keep your originals. The reviewing team may ask for further records, or for some tests to be repeated.
Cost depends on the diagnosis and treatment plan and is confirmed in a written quote after consultation.
Not always. Some lower-risk prostate cancers are managed with active surveillance, where regular tests monitor the cancer and treatment is offered if it changes. Whether this is appropriate is decided by your specialist.
It is a scan that can show prostate cancer cells in the body more sensitively than some conventional scans. It is used in specific situations, such as staging higher-risk cancer or investigating a rising PSA. Your specialist decides whether it is relevant to you.
Surgery and radiotherapy can affect urinary control, bowel function and erections, to different degrees and for different lengths of time. The team explains the risks of each option so that you can make an informed choice.
Share your records and questions. A coordinator explains how a review with a partner oncologist can be arranged. There is no obligation to proceed, and your current care continues as planned.
This is general information, not medical advice. Cancer care decisions must be made with your treating oncologist. In an emergency, contact your local emergency services. ELAVIA Global coordinates care; it does not provide medical treatment. All cancer care is delivered by independent partner clinics and their licensed oncologists.